Abstract
DNA microarray technology enables the simultaneous measurement of the transcript level of thousands of genes. Primary analysis can be done with basic statistical tools and cluster analysis, but effective and in depth analysis of the vast amount of transcription data requires integration with data from several heterogeneous data sources, such as upstream promoter sequences, genome-scale metabolic models, annotation databases and other experimental data. In this review, we discuss how experimental design, normalisation, heterogeneous data and mathematical modelling can enhance analysis of Saccharomyces cerevisiae whole genome transcription data. A special focus is on the quantitative aspects of normalisation and mathematical modelling approaches, since they are expected to play an increasing role in future DNA microarray analysis studies. Data analysis is exemplified with cluster analysis, and newly developed co-clustering methods, where the DNA microarray analysis is enhanced by integrating data from multiple, heterogeneous sources.
Keywords: systems biology, saccharomyces cerevisiae, dna microarray, cluster analysis, mathematical modelling, functional genomics
Current Genomics
Title: Enhancing Yeast Transcription Analysis Through Integration of Heterogeneous Data
Volume: 5 Issue: 8
Author(s): T. Grotkjaer and J. Nielsen
Affiliation:
Keywords: systems biology, saccharomyces cerevisiae, dna microarray, cluster analysis, mathematical modelling, functional genomics
Abstract: DNA microarray technology enables the simultaneous measurement of the transcript level of thousands of genes. Primary analysis can be done with basic statistical tools and cluster analysis, but effective and in depth analysis of the vast amount of transcription data requires integration with data from several heterogeneous data sources, such as upstream promoter sequences, genome-scale metabolic models, annotation databases and other experimental data. In this review, we discuss how experimental design, normalisation, heterogeneous data and mathematical modelling can enhance analysis of Saccharomyces cerevisiae whole genome transcription data. A special focus is on the quantitative aspects of normalisation and mathematical modelling approaches, since they are expected to play an increasing role in future DNA microarray analysis studies. Data analysis is exemplified with cluster analysis, and newly developed co-clustering methods, where the DNA microarray analysis is enhanced by integrating data from multiple, heterogeneous sources.
Export Options
About this article
Cite this article as:
Grotkjaer T. and Nielsen J., Enhancing Yeast Transcription Analysis Through Integration of Heterogeneous Data, Current Genomics 2004; 5 (8) . https://dx.doi.org/10.2174/1389202043348472
DOI https://dx.doi.org/10.2174/1389202043348472 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Conference Report
CNS & Neurological Disorders - Drug Targets Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Neuropharmacology Current Medical and Surgical Stroke Prevention Therapies for Patients with Carotid Artery Stenosis
Current Neurovascular Research Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets
Current Pharmaceutical Design Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design Aromatherapy and the Central Nerve System (CNS): Therapeutic Mechanism and its Associated Genes
Current Drug Targets Interferon alpha for Treatment of Chronic Myeloid Leukemia
Current Drug Targets Nanotechnology can Provide Therapeutic Agent by Targeting Molecular Structures of SARS-CoV-2 (COVID-19): A Mini-Review
Letters in Drug Design & Discovery Depression has a Strong Relationship to Alterations in the Immune, Endocrine and Neural System
Current Psychiatry Reviews Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia
Reviews on Recent Clinical Trials Hsp70 Protein Complexes as Drug Targets
Current Pharmaceutical Design CREB: A Multifaceted Target for Alzheimer’s Disease
Current Alzheimer Research Role of Neuromodulation and Optogenetic Manipulation in Pain Treatment
Current Neuropharmacology Helper Dependent Adenovirus Vectors: Progress and Future Prospects
Current Gene Therapy Emerging Signalling and Protein Interactions Mediated Via Metabotropic Glutamate Receptors
Current Drug Targets - CNS & Neurological Disorders Metallocarboxypeptidases: Emerging Drug Targets in Biomedicine
Current Pharmaceutical Design The Role of Transcranial Magnetic Stimulation in Treatment-Resistant Depression: A Review
Current Pharmaceutical Design The Role of Oxidative Stress in Depressive Disorders
Current Pharmaceutical Design Lipoxygenases - A Challenging Problem in Enzyme Inhibition and Drug Development
Current Enzyme Inhibition